Eledon Pharmaceuticals
ELDN
ELDN
44 hedge funds and large institutions have $91.2M invested in Eledon Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
44
Holders Change
+17
Holders Change %
+62.96%
% of All Funds
1.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
8
Reduced
6
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
KCM
Kingdon Capital Management
New York
|
+$5.35M |
| 2 |
PA
Perceptive Advisors
New York
|
+$4.5M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.39M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.33M |
| 5 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$1.53M |
Top Sellers
| 1 |
RG
Redmile Group
San Francisco,
California
|
-$2.94M |
| 2 |
Jennison Associates
New York
|
-$2.38M |
| 3 |
Morgan Stanley
New York
|
-$1.92M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.12M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.03M |
